Authors: CAMSONNE R POTTIER D BUSTANY P

Citation: R. Camsonne et al., XENOTRANSPLANTATION - CLINICAL-TRIALS AND PERSPECTIVES, La Presse medicale, 27(18), 1998, pp. 865-868

Authors: CAMSONNE R BIGOT MC BUSTANY P POTTIER D VERGNAUD M

Citation: R. Camsonne et al., MOLECULAR ASPECT OF HIV-1 RESISTANCE TO ZIDOVUDINE AND ITS REVERSAL, Trends in pharmacological sciences, 15(5), 1994, pp. 137-138

Authors: CAMSONNE R BUSTANY P BIGOT MC POTTIER D MOULIN MA

Citation: R. Camsonne et al., PERSISTENT LOW PLASMA-LEVELS OF HIV-1 IN PATIENTS ON AZT THERAPY AND ITS IMPLICATIONS, Therapie, 49(2), 1994, pp. 146-147

Authors: MICKALA P BARRE L DAUPHIN F DEBRUYNE D YOUNG AR SPECKEL D CAMSONNE R MACKENZIE ET BARON JC

Citation: P. Mickala et al., REGIONAL BRAIN DISTRIBUTION AND METABOLISM IN GUINEA-PIGS OF [C-11] CP-96,345, A NONPEPTIDE NK-1 ANTAGONIST, The Journal of nuclear medicine, 34(5), 1993, pp. 241-241

Authors: CAMSONNE R BIGOT MC FUSIB H MOULIN MA

Citation: R. Camsonne et al., THERAPEUTIC POTENTIAL OF RO 5-3335 - A NE W ACTIVE BENZODIAZEPINE AGAINST HIV-1 VIRUSES IN-VITRO, RESISTANT OR NONRESISTANT TO AZT (VOL 48,PG 105, 1993), Therapie, 48(3), 1993, pp. 276-276

Authors: CAMSONNE R BIGOT MC FUSIBET H MOULIN MA

Citation: R. Camsonne et al., THERAPEUTIC POTENTIAL OF RO-5-3335 - A NEW ACTIVE BENZODIAZEPINE AGAINST HIV-1 VIRUSES INVITRO, RESISTANT OR NON-RESISTANT TO AZT, Therapie, 48(2), 1993, pp. 105-107